Tandem Diabetes Care (TNDM) Cash from Investing Activities Growth (1y) (2014 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | -15.64% |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | -110.20% |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | -125.17% |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | -514.42% |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | -73.71% |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | -12.26% |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | -44.16% |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 618.55% |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 0.00% |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn | -250.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -250.24% |
| Mar 31, 2026 | -2,227.67% |
| Dec 31, 2025 | -398.92% |
| Sep 30, 2025 | 203.22% |
| Jun 30, 2025 | 1,742.09% |
| Mar 31, 2025 | 281.69% |
| Dec 31, 2024 | 130.21% |
| Sep 30, 2024 | 59.00% |
| Jun 30, 2024 | -162.13% |
| Mar 31, 2024 | 80.80% |
| Dec 31, 2023 | -146.35% |
| Sep 30, 2023 | -242.62% |
| Jun 30, 2023 | -10.37% |
| Mar 31, 2023 | -606.62% |
| Dec 31, 2022 | 146.57% |
| Sep 30, 2022 | 63.87% |
| Jun 30, 2022 | 109.82% |
| Mar 31, 2022 | 185.28% |
| Dec 31, 2021 | -28.83% |
| Sep 30, 2021 | 71.56% |